Objective: To explore the effect of integrated medical and nursing care in patients with pulmonary tuberculosis combined with lung cancer. Methods: From August 2021 to August 2022, 60 patients with pulmonary tuberculosis combined with lung cancer were admitted. All patients were diagnosed with pulmonary tuberculosis according to the Guidelines for the Diagnosis and Treatment of Pulmonary Tuberculosis and with lung cancer by pathology. The patients were randomly divided into two groups, with 30 cases in each group. The control group received daily nursing care, whereas the study group received integrated medical and nursing care. The sputum conversion rate, tumor remission rate, and quality of life of patients were observed and analyzed. Results: The item function score and symptom function score of the observation group were higher than those of the control group (P < 0.05); the total effective rate of the observation group was significantly higher than that of the control group (P < 0.05); the sputum conversion rate of the observation group was significantly higher than that of the control group (P < 0.05). Conclusion: For patients with pulmonary tuberculosis combined with lung cancer, the application of integrated medical and nursing care can help consolidate the treatment effect and improve the quality of life of patients; thus, it is worthy of promotion and application.
Du H, 2022, Application of Integrated Medical Care Model Combined with Systematic Respiratory Rehabilitation Training in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease. Contemporary Nurses, 29(08): 73–76.
Gong S, 2022, The Effect of Integrated Medical Care Combined with Nutritional Nursing Intervention on the Nutritional Status and Quality of Life of Hospitalized Patients with Hematological Malignancies. China Medical Herald, 19(13): 185–189.
Li W, Zheng L, Cai C, et al., 2021, Research on Risk Factors of Pulmonary Tuberculosis Combined with Lung Cancer and Analysis of Clinical Characteristics. The 33rd National Academic Conference of the Chinese Anti-Tuberculosis Association and the China Anti-Tuberculosis Science and Technology Awards Conference Papers Collection, 514–515.
Wang L, Li Q, Ren L, et al., 2021, Analysis of Curative Effect and Prognosis of Surgical Treatment for Patients with Pulmonary Tuberculosis and Lung Cancer. Modern Oncology, 29(13): 2282–2287.
Xin M, Yang H, 2020, Etiological Analysis and Nursing Strategies of Nosocomial Infection in Patients with Pulmonary Tuberculosis and Lung Cancer. Chinese Cancer Clinic and Rehabilitation, 27(10): 1265–1267.
Tang R, 2020, A Retrospective Study on the Effect of Radiotherapy and Prognosis Analysis on Patients with Pulmonary Tuberculosis and Lung Cancer, thesis, Capital University of Economics and Business.
Wang L, Wang Y, 2020, Effects of Psychological Intervention on Negative Emotions and Quality of Life in Patients with Tuberculosis and Lung Cancer. Cancer Basics and Clinics, 33(02): 129–131.
Xu B, Li Y, Liu G, et al., 2020, Comparison of CT Diagnosis and Imaging Features in Patients with Pulmonary Tuberculosis and Pulmonary Tuberculosis Complicated with Lung Cancer. Chinese Journal of Clinicians, 48(02): 184–186.
Han W, Li H, 2019, Discussion on the Characteristics of Immune Inflammatory Response and Coagulation Indicators in Patients with Pulmonary Tuberculosis and Lung Cancer. Chinese Journal of Cancer Prevention and Treatment, 26(S1): 50 + 52.
Wei L, 2019, Research on the Diagnosis of Pulmonary Tuberculosis Complicated with Lung Cancer and the Factors Affecting the Prognosis of Surgical Treatment. Chinese Medicine Guide, 17(21): 110–111.
Li X, 2019, Clinical Analysis of Pulmonary Tuberculosis Combined with Lung Cancer. Chinese Medical Association Tuberculosis Branch 2019 National Tuberculosis Academic Conference Papers Collection, 512.
Yuan C, Jiao W, Li Y, 2019, Clinical Features of Pulmonary Tuberculosis Complicated with Lung Cancer and the Application Value of Imaging Examination in Its Diagnosis. Electronic Journal of Clinical Medicine Literature, 6(07): 118.
Hai J, 2018, Risk Factors and Prognosis of Pulmonary Tuberculosis Combined with Lung Cancer. Wisdom Health, 4(07): 57–59.
Wang C, Cai Z, Zhu L, et al., 2018, Analysis of Immune Inflammatory Response and Coagulation Indicators in Patients with Pulmonary Tuberculosis and Lung Cancer. Hebei Medicine, 40(03): 380–383 + 388.
Su G, Chen Z, Cai Q, 2017, CT Manifestations and Clinical Analysis of Pulmonary Tuberculosis Combined with Lung Cancer. Chinese Journal of Integrated Traditional Chinese and Western Medicine Imaging, 15(05): 585–587.